Schedule 13G ownership disclosure

Kura Oncology Inc

Common Stock, par value $0.0001 per share · CUSIP: 50127T109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 7,561,000.00 · Class: 9.4%

  • AVERILL MASTER FUND, LTD.

    Shares: 6,922,080.00 · Class: 8.6%

  • AARON COWEN

    Shares: 7,561,000.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-002736
Form type
SCHEDULE 13G/A
Filer
Kura Oncology, Inc.
CIK
CIK 1422143
Filed
May 02, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub